Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues.
Journal: Cells
Published: September 30, 2021
Novel Roles of Follistatin/Myostatin in Transforming Growth Factor-β Signaling and Adipose Browning: Potential for Therapeutic Intervention in Obesity Related Metabolic Disorders.
Journal: Frontiers in endocrinology
Published: January 14, 2021
DUSP9-mediated reduction of pERK1/2 supports cancer stem cell-like traits and promotes triple negative breast cancer.
Journal: American journal of cancer research
Published: July 25, 2020
Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: April 06, 2018
Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis.
Journal: BMC cancer
Published: January 26, 2016
Increased Expression of Beige/Brown Adipose Markers from Host and Breast Cancer Cells Influence Xenograft Formation in Mice.
Journal: Molecular cancer research : MCR
Published: March 30, 2015
Regulation of brown adipocyte metabolism by myostatin/follistatin signaling.
Journal: Frontiers in cell and developmental biology
Published: August 21, 2014
Follistatin promotes adipocyte differentiation, browning, and energy metabolism.
Journal: Journal of lipid research
Published: January 21, 2014
Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate-sparing anabolic therapy.
Journal: Aging cell
Published: October 21, 2013
Last Updated: 09/26/2026